These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 32228502)

  • 1. The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report.
    Aversa JG; De Abreu FB; Yano S; Xi L; Hadley DW; Manoli I; Raffeld M; Sadowski SM; Nilubol N
    BMC Cancer; 2020 Mar; 20(1):256. PubMed ID: 32228502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
    Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
    Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic malignancies in Li-Fraumeni syndrome: A case report.
    Bundrant B; Gerstein Y; Arun B; DiNardo CD
    Am J Med Genet A; 2024 Jul; 194(7):e63573. PubMed ID: 38410872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal leiomyosarcoma as the initial phenotypic manifestation of Li-Fraumeni-like syndrome: a case report and review of the literature.
    Severino NP; Waisberg J; Fragoso MCBV; de Lima LGCA; Balsamo F; Henriques AC; Bianco B; de Sousa Gehrke F
    J Med Case Rep; 2022 Dec; 16(1):468. PubMed ID: 36529791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database Analysis.
    Kratz CP; Freycon C; Maxwell KN; Nichols KE; Schiffman JD; Evans DG; Achatz MI; Savage SA; Weitzel JN; Garber JE; Hainaut P; Malkin D
    JAMA Oncol; 2021 Dec; 7(12):1800-1805. PubMed ID: 34709361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome.
    Ye QL; Qi Y; Liu JJ; Hu YX; Lv Y; Lin B
    BMC Womens Health; 2023 Jun; 23(1):329. PubMed ID: 37344881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
    Kamihara J; Rana HQ; Garber JE
    Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer.
    Cho Y; Kim J; Kim Y; Jeong J; Lee KA
    Ann Lab Med; 2013 May; 33(3):212-6. PubMed ID: 23667851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene.
    Hwang SM; Lee ES; Shin SH; Kong SY
    Korean J Lab Med; 2008 Dec; 28(6):493-7. PubMed ID: 19127115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma.
    Andrade RC; de Lima MAFD; de Faria PAS; Vargas FR
    Fam Cancer; 2018 Jan; 17(1):119-122. PubMed ID: 28477317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation.
    Ferreira AM; Brondani VB; Helena VP; Charchar HLS; Zerbini MCN; Leite LAS; Hoff AO; Latronico AC; Mendonca BB; Diz MDPE; de Almeida MQ; Fragoso MCBV
    J Steroid Biochem Mol Biol; 2019 Jun; 190():250-255. PubMed ID: 30974190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings.
    Fang Z; Su Y; Sun H; Ge M; Qi Z; Hao C; Qian S; Ma X
    BMC Pediatr; 2021 Dec; 21(1):588. PubMed ID: 34961499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families.
    Llovet P; Illana FJ; Martín-Morales L; de la Hoya M; Garre P; Ibañez-Royo MD; Pérez-Segura P; Caldés T; García-Barberán V
    Fam Cancer; 2017 Oct; 16(4):567-575. PubMed ID: 28573494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Li-Fraumeni syndrome].
    Frebourg T
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors.
    Trkova M; Foretova L; Kodet R; Hedvicakova P; Sedlacek Z
    Cancer Genet Cytogenet; 2003 Aug; 145(1):60-4. PubMed ID: 12885464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and functional analysis of a Li Fraumeni syndrome family in China.
    Hu H; Liu J; Liao X; Zhang S; Li H; Lu R; Li X; Lin W; Liu M; Xia Z; Qing G; Li JD
    Sci Rep; 2016 Jan; 6():20221. PubMed ID: 26818906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Description of a new TP53 gene germline mutation in a family with the Li-Fraumeni syndrome. Genetic counselling to healthy mutation carriers].
    Balmaña J; Nomdedéu J; Díez O; Sabaté JM; Balil A; Pericay C; López López JJ; Brunet J; Baiget M; Alonso C
    Med Clin (Barc); 2002 Oct; 119(13):497-9. PubMed ID: 12406399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.